These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 406201)

  • 1. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.
    Fine DP
    Infect Immun; 1977 Apr; 16(1):124-8. PubMed ID: 406201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolysis of human erythrocytes heavily sensitized with sheep amboceptor by sheep complement chelated with EGTA or Mg2+-EGTA.
    Stankiewicz M; Jonas W
    Vet Immunol Immunopathol; 1981 Jun; 2(3):253-64. PubMed ID: 6178207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ethyleneglycoltetra-acetic acid on bactericidal activity of human serum against Escherichia coli.
    Roberts AP; Phillips R
    J Med Microbiol; 1981 May; 14(2):195-203. PubMed ID: 6785440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of divalent cation chelators and magnesium on activation of the alternative complement pathway by Fusobacterium polymorphum (nucleatum).
    Hawley CE; Falkler WA
    J Periodontal Res; 1979 Sep; 14(5):390-6. PubMed ID: 161780
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct lysis of erythrocytes by EGTA and calcium ions: implications for assessing complement activation by parasites.
    Barton AM; Cooper LE; Howell MJ
    Parasite Immunol; 1983 Jul; 5(4):427-9. PubMed ID: 6413936
    [No Abstract]   [Full Text] [Related]  

  • 8. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-complementary activity for guinea-pig and sheep complement in serum and Mg2+ EGTA plasma from various animals.
    Stankiewicz M; Jonas W; Pulford H
    N Z Vet J; 1981 Jun; 29(6):107-8. PubMed ID: 6796918
    [No Abstract]   [Full Text] [Related]  

  • 10. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Arnold RR
    Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study on the activation of the alternative pathway of complement by mouldy hay dust and thermophilic actinomycetes.
    Edwards JH
    Clin Allergy; 1976 Jan; 6(1):19-25. PubMed ID: 1248097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antibody on activation of human complement (alternative pathway) by rabbit red cells: kinetic study [proceedings].
    Hosselet M; Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1979 Oct; 87(4):816-8. PubMed ID: 93922
    [No Abstract]   [Full Text] [Related]  

  • 14. Consumption of complement in chelated and nonchelated guinea pig serum after challenge with some viral and nonviral interferon inducers.
    Rathová V; Kocisková D; Krizanová O; Borecký L
    Acta Virol; 1976 Feb; 20(1):86-8. PubMed ID: 7949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C1 in the complement activating effect of Pseudomonas aeruginosa lipopolysaccharide preparations.
    Füst G; Adám MM
    Acta Microbiol Acad Sci Hung; 1976; 23(3):239-49. PubMed ID: 828439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 shunt activation in human serum chelated with EGTA.
    Fine DP; Marney SR; Colley DG; Sergent JS; Des Prez RM
    J Immunol; 1972 Oct; 109(4):807-9. PubMed ID: 4627510
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of complement activity in turkeys: evidence for classical and alternative complement pathways.
    Ellis MG; Lamont SJ; Arp LH
    Poult Sci; 1989 May; 68(5):646-50. PubMed ID: 2666975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of phagocytic and chemiluminescence response of human polymorphonuclear neutrophils.
    Grebner JV; Mills EL; Gray GH; Quie PG
    J Lab Clin Med; 1977 Jan; 89(1):153-9. PubMed ID: 401517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative complement pathway in bovine serum: lysis of human erythrocytes.
    Pang AS; Aston WP
    Am J Vet Res; 1977 Mar; 38(3):355-9. PubMed ID: 403835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.